BMS-577098(667402-44-0)
- Name: BMS-577098
- Synonyms:BMS-577098;UQNVJOYCOQUVLD-XMMPIXPASA-N
- Molecular Formula:C28H33ClN6O3
- Molecular Weight:537.061
- CAS Registry Number:667402-44-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.667402-44-0 BMS-577098
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.667402-44-0 BMS-577098
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.667402-44-0 BMS-577098
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:BMS-577098
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.667402-44-0 BMS-577098
Assay:99% Appearance:white powder Package:drum or based on customers' requirement Storage:normal temperature storage Transportation:by sea, by air Application:We have different specifications for different applications
Min. Order:1Metric Ton
Supplier:Bluecrystal chem-union [
China (Mainland)]
Other Product
- 1044506-82-2/5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime
- 223568-55-6/EP-1013
- 586379-66-0/PH 797804
- 444606-18-2/SB-681323
- 706802-34-8/Benzenesulfonamide, N-[[[2-[4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino]carbonyl]-4-methyl-
- 1021950-26-4/Tyrosine kinase inhibitor
- 936890-98-1/OSI-027
- 802539-81-7/PHA-848125
- 552325-16-3/A-443654
- 725247-18-7/XCT 790
- 850692-43-2/WAY-260022
- 850613-22-8/WAY-260022 2HCl salt
- 1225199-26-7/Urea, N-[(3-methoxyphenyl)methyl]-N-methyl-N'-[4-(1H-pyrazol-4-yl)-2-[2-(1-pyrrolidinyl)ethoxy]phenyl]-
- 150131-78-5/6-(2-(1H-tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid
- 301836-41-9/SB 431542
- 1034614-73-7/1H-Pyrazolo[4,3-h]quinazoline-3-carboxamide, 4,5-dihydro-8-[[2-methoxy-5-(4-methyl-1-piperazinyl)phenyl]amino]-1-methyl-
- 667402-44-0/BMS-577098
- 1033836-12-2/3-Pyridinecarboxamide, 6-(3-fluorophenyl)-N-[1-(2,2,2-trifluoroethyl)-4-piperidinyl]-
- 877079-34-0/1-Pyrrolidineacetamide, 3-(acetylamino)-N-[(1S,2R)-1-[(3,5-difluorophenyl)methyl]-2-hydroxy-2-[(2R,4S)-4-hydroxy-2-pyrrolidinyl]ethyl]-3-[(1S)-1-methylpropyl]-2-oxo-a-(2-phenylethyl)-, (aS,3S)-
- 905970-15-2/1H-Pyrrole-1-acetamide, 2-(2-chlorophenyl)-N-[[(3-hydroxypropyl)amino]iminomethyl]-5-(4-propoxyphenyl)-
- 905838-55-3/3-Thiopheneacetamide, 4-(2-chlorophenyl)-N-[[(3-hydroxypropyl)amino]iminomethyl]-2-(4-propoxyphenyl)-
- 906072-41-1/[1,1':3',1''-Terphenyl]-2'-acetamide, N-(aminoiminomethyl)-4-phenoxy- (9CI)
- 951328-78-2/3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[[[[4-(acetylamino)-3,5-dichlorophenyl]methyl]amino]iminomethyl]-3-phenyl-
- 918541-86-3/4H-Imidazol-4-one, 2-amino-5-[4-fluoro-3-(2-fluoro-3-pyridinyl)phenyl]-3,5-dihydro-3-methyl-5-(4-pyridinyl)-, (5S)-
- 942505-60-4/4(3H)-Pyrimidinone, 2-amino-5,6-dihydro-6-[3'-methoxy-5'-[(methylsulfonyl)oxy][1,1'-biphenyl]-3-yl]-3,6-dimethyl-
- 916770-80-4/3,5,13-Triazatetracyclo[15.3.1.12,5.17,11]tricosa-1(21),3,7,9,11(22),17,19-heptaene-12,23-dione, 4-amino-2-methyl-
- 892873-11-9/2,3-Pyridinediamine, N3-[[5-(1H-indol-6-yl)-2-(phenylmethoxy)phenyl]methyl]-
- 937369-38-5/11-Oxa-5,6-dithia-2,9-diazatridecanoic acid, 12,12-dimethyl-10-oxo-3,8-bis(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (3R,8R)-
- 937369-39-6/2-Pyrimidinamine, 4-[2-[3-(2-furanyl)phenyl]ethyl]-6-(3-methylbutoxy)-, 2,2,2-trifluoroacetate (1:1)
- 937370-61-1/1-Isoquinolinamine, 3,4-dihydro-3-(3'-methoxy[1,1'-biphenyl]-3-yl)-